Resources
In 2024, AI revolutionized drug development in the broader pharmaceutical landscape. Companies increasingly integrated AI to accelerate research, optimize clinical trials, and personalize patient care. This trend underscores the growing importance of AI-driven solutions in enhancing patient treatment efficiencies and outcomes. OM1 is at the forefront of this transformation – our award-winning, patented AI-powered digital phenotyping[…]
December 4, 2024 CARE to Lead® with Cynthia Corsetti Listen to the full podcast >> Cynthia Corsetti is joined on the Care to Lead podcast by Dr. Joseph Zabinski, Vice President and Head of Commercial Strategy and AI at OM1. With a PhD in Health Analytics and a Master’s in Engineering Management, Dr. Zabinski discusses[…]
Register >> Friday, January 10th 2025 10:00 – 11:00 AM EST Webinar Synopsis Join us as we delve into the groundbreaking partnership between OM1 and Exact Sciences in the Falcon Registry Real-World Evidence (RWE) study. This ambitious initiative aims to enroll 25,000 patients across diverse backgrounds to evaluate the clinical impact of Multi-Cancer Early Detection[…]
December 5, 2024 1:00 – 2:00pm ET Register >> In today’s complex healthcare landscape, going beyond traditional data is essential. Join our exclusive webinar to discover how scaling qualitative data from clinical notes, combined with AI, can reveal hidden patterns in patient journeys and treatment drivers, giving you a complete view of your therapy’s impact. Explore[…]
Tuesday, November 19, 2024 2:00-3:00PM ET Register >> Clinical trial recruitment remains a major bottleneck for the pharmaceutical industry, with 85% of trials struggling to meet participant targets despite nearly $1.9 billion spent annually. The financial stakes are high, with trial delays, primarily due to patient recruitment costing companies between $600K to $8M per day.[…]
